Structures by: Enyedy É. A.
Total: 40
C13H19N5OS
C13H19N5OS
Journal of medicinal chemistry (2019) 62, 2 512-530
a=22.7776(4)Å b=6.85850(10)Å c=9.8800(2)Å
α=90° β=98.889(2)° γ=90°
C18H20ClCuN5OS,CH4O
C18H20ClCuN5OS,CH4O
Journal of medicinal chemistry (2019) 62, 2 512-530
a=16.5043(12)Å b=17.7857(12)Å c=7.1311(6)Å
α=90° β=96.241(3)° γ=90°
C14H21N5OS
C14H21N5OS
Journal of medicinal chemistry (2019) 62, 2 512-530
a=6.1236(4)Å b=7.9500(6)Å c=30.956(2)Å
α=90° β=92.419(4)° γ=90°
3(C16H22ClCuN5O2S),1.75(CH4O)
3(C16H22ClCuN5O2S),1.75(CH4O)
Journal of medicinal chemistry (2019) 62, 2 512-530
a=22.2413(7)Å b=8.3324(2)Å c=31.9121(9)Å
α=90° β=90.5654(13)° γ=90°
3(C16H22ClCuN5OS),0.75(CH4O)
3(C16H22ClCuN5OS),0.75(CH4O)
Journal of medicinal chemistry (2019) 62, 2 512-530
a=24.702(4)Å b=9.1959(14)Å c=25.064(5)Å
α=90° β=100.971(6)° γ=90°
C12H17N5OS
C12H17N5OS
Journal of medicinal chemistry (2019) 62, 2 512-530
a=11.544(3)Å b=13.204(3)Å c=10.086(3)Å
α=90° β=112.081(7)° γ=90°
C18H21N5OS
C18H21N5OS
Journal of medicinal chemistry (2019) 62, 2 512-530
a=7.1287(2)Å b=15.0536(6)Å c=16.4704(6)Å
α=90° β=97.810(2)° γ=90°
C16H23N5O2S
C16H23N5O2S
Journal of medicinal chemistry (2019) 62, 2 512-530
a=13.3622(18)Å b=5.8899(6)Å c=21.414(3)Å
α=90° β=91.631(5)° γ=90°
C13H18ClCuN5OS
C13H18ClCuN5OS
Journal of medicinal chemistry (2019) 62, 2 512-530
a=15.7566(11)Å b=14.2967(9)Å c=14.2703(10)Å
α=90° β=92.971(3)° γ=90°
(C12H18ClCuN5O2S),2(H2O)
(C12H18ClCuN5O2S),2(H2O)
Journal of medicinal chemistry (2019) 62, 2 512-530
a=9.2626(8)Å b=9.5087(8)Å c=11.0617(9)Å
α=89.565(2)° β=76.519(2)° γ=67.742(2)°
C12H16ClCuN5OS,C3H7NO
C12H16ClCuN5OS,C3H7NO
Journal of medicinal chemistry (2019) 62, 2 512-530
a=9.3959(3)Å b=19.8889(6)Å c=10.9744(3)Å
α=90° β=108.3661(7)° γ=90°
2(C13H24CoN5O2),Cl,3(F6P),0.33(H2O)
2(C13H24CoN5O2),Cl,3(F6P),0.33(H2O)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 21 6980-6988
a=15.0010(7)Å b=16.7068(8)Å c=16.6727(8)Å
α=90° β=90.2890(19)° γ=90°
C22H34FN7O4,C4H8O
C22H34FN7O4,C4H8O
Dalton transactions (Cambridge, England : 2003) (2020) 49, 21 6980-6988
a=21.6357(10)Å b=9.0441(4)Å c=17.7227(8)Å
α=90° β=126.2917(10)° γ=90°
5(H2O),2(Cl),C25H24CoN5O2
5(H2O),2(Cl),C25H24CoN5O2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 21 6980-6988
a=15.2195(12)Å b=13.7845(11)Å c=14.5792(13)Å
α=90° β=105.564(3)° γ=90°
2-((1-hydroxy-5,6,7,8-tetrahydronaphthalen-2-yl)methylene)hydrazine-1-carbothioamide '
C12H15N3OS
New Journal of Chemistry (2020) 44, 28 12154-12168
a=8.8483(7)Å b=10.5831(7)Å c=13.2516(10)Å
α=90° β=102.518(7)° γ=90°
Chloro-(2-((1-hydroxy-5,6,7,8-tetrahydronaphthalen-2-yl)methylene)hydrazine-1-carbothioamide)-copper(II)
C12H14ClCuN3OS
New Journal of Chemistry (2020) 44, 28 12154-12168
a=12.3620(7)Å b=9.1718(5)Å c=24.3156(13)Å
α=90° β=90° γ=90°
[Rh (n5-C5Me5)(dmen)Cl](CF3SO3)
C14H27ClN2Rh,CF3O3S
New Journal of Chemistry (2018) 42, 13 11174
a=8.5159(3)Å b=9.7262(4)Å c=24.5900(10)Å
α=90° β=90° γ=90°
[Rh(n5-C5Me5)(pin)Cl](Cl)
2(C16H23ClN2Rh),0.5(C2H8O2),2(Cl)
New Journal of Chemistry (2018) 42, 13 11174
a=8.6742(3)Å b=14.5573(6)Å c=14.6705(6)Å
α=90° β=104.1107(13)° γ=90°
[Rh(n5-C5Me5)(tmeda)Cl](CF3SO3)
3(C16H31ClN2Rh),3(CF3O3S),2(H2O)
New Journal of Chemistry (2018) 42, 13 11174
a=13.0112(4)Å b=37.6730(11)Å c=13.6054(4)Å
α=90° β=91.5748(9)° γ=90°
(OC-6-33)-Dichlorido(ethane-1,2-diamine)[bis(2-(2,5-dioxo-2,5- dihydro-1H-pyrrol-1-yl)ethylcarbamoyloxy)platinum(IV)]
C16H22Cl2N6O8Pt
Chemical communications (Cambridge, England) (2013) 49, 22 2249-2251
a=26.9636(16)Å b=7.7770(4)Å c=11.3395(6)Å
α=90.00° β=106.782(2)° γ=90.00°
7-(piperidin-1-ylmethyl)quinolin-8-ol
C15H18N2O
Dalton transactions (Cambridge, England : 2003) (2018) 47, 47 17032-17045
a=8.9362(7)Å b=11.4735(10)Å c=12.7458(11)Å
α=90° β=90° γ=90°
Bis(7-(morpholin-4-ylmethyl)quinolin-8-ol)-bis-(μ-2-(7-(morpholin-4-ylmethyl)quinolin-8-ol)-di-copper(II) tetrachlorid dimethanol solvate dihydrate
C56H64Cu2N8O8,2(CH4O),Cl4,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 47 17032-17045
a=25.0347(19)Å b=10.5428(7)Å c=23.7514(17)Å
α=90° β=93.299(2)° γ=90°
5-chloro-7-{[(2-fluorobenzyl)amino]methyl}quinolin-8-ol
C17H15ClFN2O,Cl,H2O
Dalton transactions (Cambridge, England : 2003) (2018) 47, 47 17032-17045
a=7.0220(3)Å b=9.4970(5)Å c=13.8230(6)Å
α=95.430(2)° β=101.7900(10)° γ=99.440(2)°
Bis(7-(piperidin-1-ylmethyl)quinolin-8-ol)-copper(II) dichlorid
C30H36CuN4O2,2(Cl)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 47 17032-17045
a=6.5336(2)Å b=10.8906(4)Å c=20.7810(7)Å
α=90° β=91.408(2)° γ=90°
Bis-(5-chloro-7{[(2-fluorobenzyl)amino]methyl}quinolin-8-ol)-aqua-copper(II) zinctetrachlorid methanol solvate
C35H32Cl2CuF2N4O3,Cl4Zn,CH4O
Dalton transactions (Cambridge, England : 2003) (2018) 47, 47 17032-17045
a=11.8498(12)Å b=12.9144(11)Å c=14.7891(17)Å
α=76.700(3)° β=72.214(3)° γ=67.890(3)°
Chloro-(η^5^-pentamethylcyclopentadienyl)-(quinolin-8-olato)- rhodium'
C19H21ClNORh,3(H2O)
Dalton transactions (Cambridge, England : 2003) (2017) 46, 13 4382-4396
a=15.9461(6)Å b=16.3041(6)Å c=7.6492(3)Å
α=90° β=97.1320(10)° γ=90°
C19H26ClN4O3PdS,Cl
C19H26ClN4O3PdS,Cl
Dalton transactions (Cambridge, England : 2003) (2016) 45, 34 13427-13439
a=6.9628(5)Å b=18.5602(13)Å c=17.4498(12)Å
α=90° β=101.011(2)° γ=90°
C19H26ClN4NiO3S,Cl
C19H26ClN4NiO3S,Cl
Dalton transactions (Cambridge, England : 2003) (2016) 45, 34 13427-13439
a=6.9292(2)Å b=18.4742(8)Å c=17.4103(7)Å
α=90° β=101.171(2)° γ=90°
4(C19H26N4O3S),5(CH4O)
4(C19H26N4O3S),5(CH4O)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 34 13427-13439
a=10.5018(4)Å b=24.7063(9)Å c=16.9193(7)Å
α=90° β=90.967(2)° γ=90°
C20H28Cl2CuN4O3S
C20H28Cl2CuN4O3S
Dalton transactions (Cambridge, England : 2003) (2016) 45, 34 13427-13439
a=20.3880(16)Å b=14.1122(7)Å c=15.9901(12)Å
α=90° β=100.503(6)° γ=90°
C19H17NO4
C19H17NO4
Dalton transactions (Cambridge, England : 2003) (2010) 39, 45 10854-10865
a=11.8125(13)Å b=11.1729(13)Å c=11.8630(13)Å
α=90.00° β=103.765(6)° γ=90.00°
C13H19ClCuN6S,0.15(CH4O)
C13H19ClCuN6S,0.15(CH4O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 9071-9090
a=7.6944(5)Å b=17.4966(10)Å c=13.1409(8)Å
α=90.00° β=102.615(2)° γ=90.00°
C14H20ClCuN5OS,0.925(CH4O)
C14H20ClCuN5OS,0.925(CH4O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 9071-9090
a=9.8676(7)Å b=12.0982(8)Å c=16.6060(10)Å
α=86.450(3)° β=74.015(3)° γ=77.176(3)°
C17H21ClCuN6O3S
C17H21ClCuN6O3S
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 9071-9090
a=8.0848(4)Å b=12.1277(6)Å c=12.3563(5)Å
α=63.8664(17)° β=83.4075(18)° γ=73.0771(17)°
C15H24ClCuN6S,Cl,2(H2O)
C15H24ClCuN6S,Cl,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 9071-9090
a=7.6629(3)Å b=11.7864(3)Å c=13.0949(4)Å
α=72.1141(11)° β=73.6132(12)° γ=74.3107(11)°
2(C12H16ClCuN5OS),C4H10O
2(C12H16ClCuN5OS),C4H10O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 19 9071-9090
a=7.7969(6)Å b=17.4139(14)Å c=13.1450(10)Å
α=90.00° β=103.700(2)° γ=90.00°
C13H15CuN5O2S,2(H2O)
C13H15CuN5O2S,2(H2O)
Inorganic Chemistry (2013) 52, 8895-8908
a=7.49000(10)Å b=10.00060(10)Å c=21.5284(3)Å
α=90.00° β=90.00° γ=90.00°
Di(μ-acetato-κ^2^O,O)-(2-((3-((2-(11H-indolo[3,2-c]quinolin-6-yl-κN^5^) hydrazono-κN^13^)methyl)-5-methyl-2-oxidobenzyl-κO^1^) (2-methoxy-2-oxoethyl-κO^5^)aminoκN^23^) acetato-κO^2^)dicopper(II) trimethanol solvate
C33H31Cu2N5O9,3(CH4O)
Inorganic Chemistry (2013) 52, 10137-10146
a=11.1929(5)Å b=11.3582(5)Å c=15.4454(7)Å
α=71.745(2)° β=76.682(3)° γ=81.086(2)°
[Chlorido-(3-methyl-D-prolinium-5-methyl-2-oxido-benzaldehyde- thiosemicarbazone)copper(II)]chloride
C15H20ClCuN4O3S,Cl
Inorganic Chemistry (2012) 51, 9309-9321
a=7.3130(3)Å b=21.8734(8)Å c=11.7535(5)Å
α=90.00° β=99.423(2)° γ=90.00°
Di(μ-acetato-κ^2^O,O)-(2-((3-((2-(11H-indolo[3,2-c]quinolin-6-yl-κN^5^) hydrazono-κN^13^)methyl)-5-methyl-2-oxidobenzyl-κO^1^) (2-methoxy-2-oxoethyl-κO^5^)aminoκN^23^) acetato-κO^2^)dizinc(II) dimethanol solvate
C33H31N5O9Zn2,2(CH4O)
Inorganic Chemistry (2013) 52, 10137-10146
a=10.7024(5)Å b=11.6277(5)Å c=15.4646(8)Å
α=99.404(3)° β=105.532(3)° γ=94.840(3)°